Currently, there are 127.78M common shares owned by the public and among those 126.38M shares have been available to trade.
The company’s stock has a 5-day price change of 4.98% and 8.58% over the past three months. EXTR shares are trading -28.29% year to date (YTD), with the 12-month market performance down to -47.53% lower. It has a 12-month low price of $10.49 and touched a high of $32.73 over the same period. EXTR has an average intraday trading volume of 1.98 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.57%, 11.58%, and -19.35% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Extreme Networks Inc. (NASDAQ: EXTR) shares accounts for 93.59% of the company’s 127.78M shares outstanding.
It has a market capitalization of $1.64B and a beta (3y monthly) value of 1.78. The earnings-per-share (ttm) stands at -$0.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.04% over the week and 3.43% over the month.
Earnings per share for the fiscal year are expected to decrease by -51.56%, and 40.18% over the next financial year.
Looking at the support for the EXTR, a number of firms have released research notes about the stock. Craig Hallum stated their Buy rating for the stock in a research note on May 16, 2024, with the firm’s price target at $14. Rosenblatt coverage for the Extreme Networks Inc. (EXTR) stock in a research note released on May 02, 2024 offered a Buy rating with a price target of $17. B. Riley Securities was of a view on April 15, 2024 that the stock is Buy, while UBS gave the stock Neutral rating on February 01, 2024, issuing a price target of $22- $14. Rosenblatt on their part issued Neutral rating on February 01, 2024.
